Sage Therapeutics (SAGE) had a notable insider buy on 11/10 when the CEO Barry Greene bought 14,500 shares at $34.48 for $500k in total and this increases his stake by +45%. . This follows a director buying 8,000 shares at $31.45 back in May for a to...